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The aim of this study was to evaluate the potential of two probiotic preparations, containing live lactic acid bacteria (Lactococcus
lactis CECT 539 and Lactobacillus casei CECT 4043) and their products of fermentation (organic acids and bacteriocins), as a
replacement for antibiotics in stimulating health and growth of broiler chickens. The eﬀects of the supplementation of both
preparations (with proven probiotic eﬀect in weaned piglets) and an antibiotic (avilamycin) on body weight gain (BWG), feed
intake (FI), feed consumption eﬃciency (FCE), relative intestinal weight, and intestinal microbiota counts were studied in 1-
day posthatch chickens. The experiments were conducted with medium-growth Sasso X44 chickens housed in cages and with
nutritional stressed Ross 308 broiler distributed in pens. Consumption of the diﬀerent diets did not aﬀect signiﬁcantly the ﬁnal
coliform counts in Sasso X44 chickens. However, counts of lactic acid bacteria and mesophilic microorganisms were higher in
the animals receiving the two probiotic preparations (P<0.05). In the second experiment, although no diﬀerences in BWG were
observed between treatments, Ross 308 broilers receiving the probiotic Lactobacillus preparation exhibited the lowest FCE values
and were considered the most eﬃcient at converting feed into live weight.
1.Introduction
Antibiotics have been extensively used in animal feed to
improve production in poultry and piglet industries [1].
However, the use of these substances as growth promoters
can lead to the development of antibiotic resistances. Such
resistances can occur not only in pathogenic bacteria [2, 3],
which can be transferred from poultry products to human
population [4], but also in commensal bacteria [5], consti-
tuting a reservoir of resistance genes for pathogenic bacteria
[6]. In recent years, the interest in ﬁnding alternatives to the
use of antibiotics in animal feed has been increased due to
the ban of subtherapeutic antibiotic usage in Europe. The
research is mostly focused on incorporating into animal
feeds, substances derived from plants, animals, bacteria and
fungi, as well as organic acid, essential oils, and bacteriocins,
that could interfere in colonisation of pathogens [7–9].
Duetotheirpotentialtoreduceentericdiseaseinpoultry,
probiotics are considered to be a good alternative to the use
of antibiotics [10]. The production of antimicrobial com-
pounds (mainly organic acids and bacteriocins) by many
lactic acid bacteria (LAB) into the intestine has provided
these organisms with a competitive advantage over other
microorganisms to be used as probiotics [11, 12]. Moreover,
the presence of some Lactobacillus in the chicken gastrointes-
tinaltract(GIT)hasbeendescribedtobeofgreatimportance
for regulating the composition of the intestinal microﬂora,
developing immunity of the intestine, and promoting the
health of chickens [13].
The administration of highly concentrated bacterial cul-
tures, containing both the live cells and their products of
fermentation, was an eﬀective way to promote body weight
gain (BWG) and improve feed conversion eﬃciency (FCE) in
chickens [6, 14–16]. In fact, probiotics are used nowadays by2 The Scientiﬁc World Journal
compound feed industry to improve the poultry production
[17, 18].
In a previous work [1], two potentially probiotic prepa-
rations, containing the live cells of Lactococcus lactis CECT
539 or Lactobacillus casei CECT 4043, as well as their fer-
mentation products, were evaluated as probiotic additives to
replace antibiotics in weaning pig diets. The administration
of these potentially probiotic preparations improved BWG
and feed intake (FI). In the same study, Guerra et al. [1]
observed that the two above-mentioned LAB fulﬁl many
of the probiotic criteria [19], because they are (i) non-
pathogenic, (ii) able to survive during processing and stor-
age, (iii) resistant to bile and acid environment, and (iv) pro-
ducer of inhibitory compounds (organic acids and antibac-
terial activity).
Since probiotic eﬀects are strain dependent [1]a n dm a y
also depend on the host and their immunologic state [20],
the observed probiotic eﬀects of the L. lactis CECT 539 and
Lact. casei CECT 4043 preparations in piglets might not be
observed in other host entities. Therefore, in an attempt
for testing the latter hypothesis, the L. lactis CECT 539 and
Lact. casei CECT 4043 preparations (containing both the live
cells and their products of fermentation) were evaluated as a
replacement for antibiotics in stimulating health and growth
of broilers.
2.MaterialsandMethods
2.1. Bacterial Strains. Lactobacillus casei subsp. casei CECT
4043 (a high lactic acid-producing strain) and Lactococcus
lactis subsp. lactis CECT 539 (a nisin-producing strain) were
obtained from the Spanish Type Culture Collection (CECT).
StockculturesofbothLABstrainsweremaintainedat −40◦C
in nutrient broth supplemented with 15% glycerol. Working
cultures, maintained at 4◦C on de Man, Rogosa, and Sharpe
(MRS, Cultimed) agar, were prepared monthly from frozen
stock cultures.
2.2. Production of the Potentially Probiotic Preparations of the
Two LAB. The potentially probiotic preparations of the
strains CECT 4043 and CECT 539 were obtained by using
a fed-batch fermentation technique based on successive real-
kalizations of the culture media, which were prepared with
cheese whey from a local dairy plant [21]. The fermentation
medium was a diluted whey (DW: concentrated whey (CW)
mixed with wash water), which contained (ing/L): total
sugars, 20.54; total nitrogen, 0.45; total phosphorus, 0.25,
and soluble proteins, 2.04 [1]. The substrates used as feeding
media were a concentrated lactose solution (400g/L) and
CW medium. The latter substrate contained (in g/L): total
sugars, 48.11; total nitrogen, 1.05; total phosphorus, 0.43,
and soluble proteins, 5.02 [1].
The realkalized fed-batch cultures with each LAB strain
were carried out at a controlled temperature of 30◦Ci na
10L bench top bioreactor tailored at an agitation speed of
200rpm and continuous record of pH as described before
[1, 21, 22].
Table 1: Mean composition of the probiotic preparations obtained
from realkalized fed-batch cultures of Lact. casei CECT 4043 and L.
lactis CECT 539.
Composition CECT 4043 CECT 539
Total sugars (g/L) 16.16 19.71
Nitrogen (g/L) 1.37 1.59
Phosphorous (g/L) 0.07 0.36
Protein (g/L) 6.09 9.15
pH 7.00 7.00
Viable cells (CFU/mL)1 3.69 × 109 3.34 × 109
Antibacterial activity (AU/mL)2 28.85 164.49
Lactic acid (g/L) 33.47 17.54
Formic acid (g/L) 0.10 0.85
1CFU: colony-forming units.
2AU: activity units.
At the end of each realkalized fed-batch culture, the me-
dia were adjusted to pH 7.0 to facilitate the adsorption of
the bacteriocin onto the producer strains [23]. Subsequently,
the cultures (cells plus the fermentation products) were
preserved at −20◦C with skim milk powder (300g/L of fer-
mented medium) until further use, as indicated by Guerra
et al. [1].
2.3. Preparation of the Experimental Feeds. The potentially
probiotic preparations of the two LAB (composition in
Table 1)weredefrostedandmixedwiththecommercialmash
broiler feed (named basal diet which composition is showed
in Table 2) using an end-over-end mixer in a ratio of 20mL
probiotic preparation/kg feed. No pellet was made with the
experimental feeds. This can contribute to increase feed
wastage and, so, to increase feed conversion values; however
for comparative purposes between treatments it is worth
keeping high probiotic counts. The probiotic preparations
were added weekly to the basal diets as recommended by
Guerra et al. [1]. In the group receiving the antibiotic, the
basal diet was supplemented with 10mg of avilamycin per kg
of feed.
2.4. Analytical Determinations. The concentrations of total
sugars, phosphorous, nitrogen, protein, lactic acid, formic
acid and antibacterial activity in the probiotic preparations
were determined by methods previously described [23, 24].
2.5. Experimental Animals and Management. The two exper-
imentswerecarriedoutintheexperimentalfarmofCOREN,
S.C.L. (Ourense, Spain). One-day-old males were used in
both experiments and fed ad libitum. Four experimental
groups were assayed: a control group fed with unsupple-
mented basal diet, a second group fed with the probiotic
Lactobacillus casei preparation, a third group fed with the
probiotic Lactococcus lactis preparation, and an antibiotic
(avilamycin) supplemented fed group.
2.5.1. Experiment 1. A total of 120 medium-growth Sasso
X44 chickens were distributed into 12 replicates of 10 birdsThe Scientiﬁc World Journal 3
Table 2: Composition of the basal diets of both experiments.
Composition (g/Kg of diet) Experiment 1 Experiment 2
Barley 20.0 70.0
Wheat 300.0 500.0
Maize 300.0 0.0
Animal fat 15.0 48.2
Full fat soybean 35.0 28.6
Soybean meal 440 272.0 20.0
Gluten feed 20.0 0.0
Soybean meal 470 0.0 287.4
Sodium bicarbonate 0.3 0.5
Calcium carbonate 14.0 11.2
Monocalcium phosphate 13.5 19.6
Sodium chloride 3.9 3.5
L-Choline 75 0.9 0.9
DL(+)-Methionine 1.9 3.4
L-Threonine 0.0 0.6
L-Lysine 0.7 3.3
Coccidiostatea 0.6 0.6
Mineral premixb 1.1 1.1
Vitamin premixc 1.1 1.1
aC-Maxiban G150.
bPremix contained per kg of diet: Co 0.15g, Cu 8g, Fe 40g, I 1.9g, Mn 80g,
Se 0.25g, Zn 65g.
cPremix contained per kg of diet: Vitamin A 12000IU, Vitamin D3 4000IU,
Vitamin E 50IU, Vitamin K 3.5mg, Vitamin B1 2.5mg, Vitamin B2 7mg,
pantothenic acid 14mg, Vitamin B6 3mg,VitaminB 12 15mg, nicotinic acid
55mg, folic acid 1mg, biotin 0.17mg.
each (three replicates per treatment) during an experimental
period of 42 days. Each replicate was housed separately in
individual metal cages (75 × 40 × 105cm), situated at 80cm
from the ﬂoor to limit the consumption of faeces. The cycle
of light was natural environment (12h of daylight) and the
temperature during the treatment, maintained with propane
heating, was the following: ﬁrst week, 32◦C, second week,
30◦C, and third week, 26◦C. From day 21, the temperature
was maintained between 20 and 24◦C. The BWG, FI, and
FCEwerecalculatedat7,14,21,and42daysaftertheanimals
received the experimental diets.
2.5.2. Experiment 2. A total of 1200 commercial Ross
308 broiler chicks were distributed into 24 pens
(12.7animals/m2) of 50 birds (six replicates per treatment)
during an experimental period of 31 days on wood shaving
ﬂoor to simulate farm conditions. According to the good
manufacturing practices of Coren S.C.L., the light program
consisted in 24h for the ﬁrst 12 days, one hour alternating
light and dark from day 15 to day 21, and 2h alternating
light and dark from day 21 until the end of the experiment.
The temperature program was similar to that of experiment
1. BWG, FI, and FCE were determined at 16 and 31 days.
2.6. Sample Collection. At 7, 14, 21, and 42 days (in case of
experiment1)andat7,16,and31days(incaseofexperiment
2), 24 chickens (2 per replicate, so 6 per treatment) in
experiment 1 and 48 chickens (2 per replicate, so 12 per
treatment) in experiment 2 were chosen randomly and
sacriﬁced.Animalmanagementfollowedtheanimalcareand
welfare guidelines of COREN S.C.L. The abdominal cavity
was opened and the gastrointestinal tract was excised to
determine the number of bacterial counts. In experiment 1
thewholegastrointestinaltract,fromcroptocaeca,wasused.
In experiment 2 only the caeca were excised.
2.7. Bacterial Counts in Gastrointestinal Samples. All gas-
trointestinal samples emptied of faeces were weighed and
placed in a sterile bag with sterile phosphate buﬀered saline
(PBS, pH 7, 100mM NaCl) in proportion 1:10 (w/v)
and pummelled for 2min in a Stomacher. Tenfold serial
dilutions in sterile PBS were performed up to 107 and
aliquots (0.1mL) of each dilution were pour-plated in MRS
agar (Cultimed), eosin methylene blue agar (EMB, Levine
Formulation, Cultimed), and Tryptone Soy Agar (TSA,
Cultimed) to determine the main representative cultivable
LAB microbiota, coliforms, and total mesophilic counts,
respectively. The plates were incubated at 37 ± 1◦Cf o r2 4h
for coliform counts and at 30 ± 1◦C for 24h and 48h for
mesophilic bacteria and LAB counts, respectively. The results
were expressed as the number of colony-forming units per
gram (wet weight) of intestinal content (CFU/g).
2.8. Statistical Analysis. Data on growth performance, bac-
terial counts, and relative intestine weight were statistically
analyzed using the software package SPSS 13.0 for Windows
(Release 13.0.1; SPSS Inc., Chicago, IL, 2004). Viable counts
in the intestinal content were transformed by logarithm
(log10) before statistical analysis. Normal distribution of data
as well as the independence and homogeneity of variances
among treatment groups was veriﬁed by looking at the dis-
tribution of the data and the Fisher F-test (which is included
in the t-test output), respectively. A one-way analysis of
variance(ANOVA) with thestep-down multiple-stage F post
hoc test (Ryan-Einot-Gabriel-Welsch multiple F-test (P =
0.05) wasused to distinguish treatment mean diﬀerences [1].
3. Results
3.1. Probiotic Preparations. The mean compositions of the
two probiotic preparations obtained from the realkalized
fed-batchfermentationswithLact.caseiandL.lactison whey
are shown in Table 1.A si tc a nb eo b s e r v e d ,b o t hp r o b i o t i c
preparations contained relatively high concentrations of
inhibitory products (lactic acid and antibacterial activity)
and relatively low concentrations of formic acid, which were
accumulated at diﬀerent concentrations in the culture media
during the realkalized fed-batch fermentations.
In addition, both preparations were characterized with
high concentrations of viable cells (3.69 × 109 CFU/mL in
case of Lact. casei and 3.34 × 109 CFU/mL in case of L.
lactis). Therefore, addition of the two potential probiotic
preparations at the dose of 20mL/kg of feed oﬀered the
possibility of preparing feeds with viable cells concentrations
of 7.38 × 107 CFU of Lact. casei or 6.68 × 107 CFU of L. lactis4 The Scientiﬁc World Journal
Table 3: Eﬀect of dietary probiotic preparations (CECT 4043, CECT 539) or antibiotic (avilamycin) on growth performance parameters of
medium-growth Sasso X44 chickens during 42 days (experiment 1).
Treatment1 BWG (g per chicken) FI (g per chicken) FCE (g of FI/g of BWG) Relative intestine weight (g of organ/g of BW)
Chicken performance (days 1–21)
Control 436 ±21a 749 ±16a 1.72 ±0.05 0.066 ±0.006
CECT 4043 425 ±5ab 754 ±9a 1.78 ±0.01 0.064 ±0.003
CECT 539 395 ±13b 654 ±80b 1.65 ±0.15 0.067 ±0.007
Avilamycin 440 ±17a 766 ±15a 1.74 ±0.05 0.060 ±0.009
F 5.477 4.630 1.179 0.965
d.f. (N)2 3 (12) 3 (12) 3 (12) 3 (24)
Chicken performance (days 1–42)
Control 1336 ±33 2864 ±140 2.14 ±0.07 0.046 ±0.004a
CECT 4043 1348 ±33 2858 ±97 2.12 ±0.05 0.045 ±0.002a
CECT 539 1314 ±16 2800 ±120 2.13 ±0.07 0.048 ±0.006a
Avilamycin 1503 ±16 3084 ±84 2.06 ±0.14 0.040 ±0.004b
F 3.935 3.741 0.584 4.242
d.f. (N) 3 (12) 3 (12) 3 (12) 3 (24)
a–cMeans within columns followed by diﬀerent letters are signiﬁcantly diﬀerent (P<0.05).
1The chickens from the control group were not given probiotic preparations or antibiotic. The chickens in the CECT 4043, CECT 539, and avilamycin groups
were fed with Lactobacillus casei CECT 4043 (7.38 × 1010 CFU/Kg diet), Lactococcus lactis CECT 539 (6.68 × 1010CFU/Kg diet) preparations, and avilamycin
(10mg/Kg diet), respectively. BWG: body weight gain, FI: feed intake, FCE: feed conversion eﬃciency.
2d.f.: degree of freedom. N:n u m b e ro fs a m p l e s .
per g of feed. Both concentrations are higher than that of the
recommended dose of viable probiotic cells (106 CFU per g
or mL) necessary to observe beneﬁcial eﬀects [25, 26].
3.2. Performance of Medium-Growth Sasso X44 Chickens in
Cages (Experiment 1). The BWG, FI, and FCE values of
medium-growth Sasso X44 chickens fed with the diﬀerent
diets during the experimental period are shown in Table 3.
Broilers fed the L. lactis CECT 539 preparation showed
the lowest values of BWG and FI during the ﬁrst 21d of
treatment (P<0.05), but no diﬀerences were found for
FCE among groups. In addition, for the entire experimental
period, diets did not aﬀect any of the growth performance
parameters studied.
Interestingly, at the end of the experiment (42d), avil-
amycin feeding resulted in a reduction (P<0.05) in the
mean relative intestinal weight (0.040g of organ/g of BW)
in comparison to the control group (0.046g of organ/g of
BW) and the groups receiving Lact. casei (0.045g of organ/g
of BW) and L. lactis (0.048g of organ/g of BW). However,
no signiﬁcant diﬀerences in the relative intestine weight were
observed between the two groups receiving the two probiotic
preparations and the control group (Table 3).
3.3. Eﬀect of the Feeding with Probiotic Preparations on the
Intestinal Microbiota of Medium-Growth Sasso X44 Chickens
in Cages (Experiment 1). The viable counts of the diﬀerent
groupsofbacteriaanalyzedinthistrialareshowninFigure 1.
With regard to the coliforms (upper part of Figure 1), no sig-
niﬁcant diﬀerences were found in total counts among diets,
probably because birds were placed in cages elevated 80cm
above the barn ﬂoor, where no reconsume of faeces occurred.
However, in broilers fed the probiotic preparations, the
ﬁnal average LAB counts (8.16 log10 CFU/g in case of strain
CECT 4043 and 8.18 log10 CFU/g in case of strain CECT
539) were higher (P<0.10) than that (7.64 log10 CFU/g) of
the control group (middle part of Figure 1). In chickens fed
avilamycin, the average LAB counts decreased progressively
until reaching a ﬁnal value at the end of the experiment (6.35
log10 CFU/g) signiﬁcantly lower (P<0.05) than those ﬁnal
levels obtained in the other three groups (middle part of
Figure 1).
As expected, the ﬁnal average mesophilic counts in the
groups fed the probiotic preparations (7.66 log10 CFU/g in
case of strain CECT 4043 and 7.65 log10 CFU/g in case of
strain CECT 539) by day 42 were signiﬁcantly higher (P<
0.05) than that (7.21 log10 CFU/g) of the avilamycin group
(lower part of Figure 1).
3.4. Performance of Broiler Chickens in Pens with Wood Shav-
ing Litter and Subjected to Nutritional Stress (Experiment 2).
Table 4 summarizes the eﬀect of dietary probiotic prepara-
tions or avilamycin on growth performance parameters in
stressed chickens. With regard to the ﬁnal BWG, no signiﬁ-
cant diﬀerences were observed among treatments during the
whole experimental period. However, broilers fed avilamycin
had higher FCE values (P<0.05) than the other three
groups. At 16 days of treatment, the FCE values in the groups
fed the probiotic preparations (1.86 ± 0.08 in case of strain
CECT 4043 and 1.82±0.08 in case of strain CECT 539) were
lower than those of the avilamycin (2.15 ± 0.18, P<0.05)
and control (2.04 ± 0.20) groups. Although the FCE values
increased in the four groups at the end of the experimental
period, broilers fed Lact. casei CECT 4043 preparation were
more eﬃcient than those fed avilamycin (P<0.05) orThe Scientiﬁc World Journal 5
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Figure 1: Viable plate counts (means ± standard deviations) of coliforms, lactic acid bacteria and mesophilic bacteria in the intestinal
content of medium-growth Sasso X44 chickens fed with a non supplemented diet (control), or diets supplemented with the probiotic Lact.
casei CECT 4043 or L. lactis CECT 539 preparations or avilamycin. a–cMeans within columns followed by diﬀerent letters are signiﬁcantly
(P<0.05).
unsupplemented feed (P<0.1 0 ) .I nt h ep r e s e n ts t u d y ,m o r -
tality was not signiﬁcantly (P<0.05) aﬀected by probiotic
treatment over the experimental period (data not shown).
Although, at the end of the experiment, the relative
weight of caeca values in all the groups were approximately
1% of the animal weight, as described by Redig [27], no
signiﬁcant diﬀerences were found between broilers fed with
the diﬀerent diets.
3.5. Total Coliform Counts in the Caeca of Ross 308 Broiler
Chickens (Experiment 2). Coliform counts in the caeca were
highly variable throughout the assay, with large variance of
values within individual treatment groups and variations
observed in counts at diﬀerent time points (Figure 2). Con-
sequently, no signiﬁcant diﬀerence in fecal coliform counts
(P<0.05) was observed in the four groups during the ex-
perimental period.
4. Discussion
The results obtained in experiment 1 showed that, at the end
of the experimental period (42 days), consumption of the
diﬀerent diets did not aﬀect any of the growth performance
parametersofmedium-growthSassoX44chickens.However,
a signiﬁcant decrease in the relative intestinal weight (P<
0.05) was observed in the group receiving avilamycin as
compared with the nontreated control group and the groups
fed diets with the probiotic preparations. A similar result was
observed when bacitracin and virginiamycin, two antibiotic
growth promoters, were assayed as additives in corn-soybean
meal diets for Ross × Ross broiler chicks [28]. This decrease
in the intestinal weight because of consumption of antibi-
otics has been documented by other authors [29, 30]b e f o r e
knowing their positive eﬀect as growth promoters in chicks.
Reduction in intestinal weight has been associated to a
thinning of the gastrointestinal walls tract probably due to
an inhibition of the microbial production of polyamines and
volatile fatty acids [31].
Interestingly, in the present study, the groups receiving
the two probiotic preparations had similar relative intestine
weights than the group fed control diet (Table 3), suggesting
thatthemechanismofactionofavilamycinandtheprobiotic
preparations was diﬀerent.6 The Scientiﬁc World Journal
Table 4: Eﬀect of dietary probiotic preparations (CECT 4043, CECT 539) or antibiotic (avilamycin) on growth performance parameters of
Ross 308 broiler chickens subjected to nutritional stress (experiment 2).
Treatment1 BWG (g per chicken) FI (g per chicken) FCE (g of FI/g of BWG) Relative caeca weight (g of organ/g of BW)
Chicken performance (days 1–16)
Control 397 ±34 805 ±42a 2.04 ±0.20ba 0.012 ±0.003
CECT 4043 387 ±13 721 ±9b 1.86 ±0.08cb 0.011 ±0.003
CECT 539 388 ±15 706 ±18b 1.82 ±0.08c 0.011 ±0.002
Avilamycin 369 ±39 789 ±47a 2.15 ±0.18a 0.012 ±0.003
F 1.025 13.042 6.810 1.669
d.f (N)2 3 (24) 3 (24) 3 (24) 3 (48)
Chicken performance (days 1–31)
Control 1377 ±82 2909 ±154 2.11 ±0.10ab 0.009 ±0.003
CECT 4043 1388 ±42 2802 ±34 2.02 ±0.05b 0.009 ±0.003
CECT 539 1364 ±46 2812 ±56 2.06 ±0.07ab 0.008 ±0.003
Avilamycin 1319 ±87 2872 ±33 2.18 ±0.12a 0.007 ±0.003
F 1.221 2.135 3.689 3.446
d.f (N) 3 (24) 3 (24) 3 (24) 3 (44)
a–cMeans within columns followed by diﬀerent letters are signiﬁcantly diﬀerent (P<0.05).
1The chickens from the control group were not given probiotic preparations or antibiotic. The chickens in the CECT 4043, CECT 539, and avilamycin groups
were fed with Lactobacillus casei CECT 4043 (7.38 × 1010 CFU/Kg diet), Lactococcus lactis CECT 539 (6.68 × 1010CFU/Kg diet) preparations, and avilamycin
(10mg/Kg diet), respectively. BWG: body weight gain, FI: feed intake, FCE: feed conversion eﬃciency.
2d.f.: degree of freedom. N :n u m b e ro fs a m p l e s .
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Figure 2: Viable plate counts (means ± standard deviations) of col-
iformsinthecaecaofRoss308broilersfedwithanonsupplemented
diet (control) or diets supplemented with the probiotic Lact. casei
CECT 4043 or L. lactis CECT 539 preparations or avilamycin.
In the ﬁrst experiment, no signiﬁcant diﬀerences were
found in total coliform counts among groups (Figure 1). In
this way, when a pathogen colonizes the intestine, infection
in the other chickens happens by horizontal transmission
through faeces [32], but, in this assay, chickens had a mini-
mum contact with their faeces and, consequently, the growth
of enteric bacterial contamination was avoided.
At the end of the experimental period, LAB counts in
the probiotic fed groups were higher than that of the control
group. The strains CECT 4043 and CECT 539 used in this
experiment have proven to be resistant to acid and bile
salts in vitro under conditions that mimic the animal GIT
environment [1]. Therefore, the higher LAB counts found
in chickens fed probiotics could be due to the presence
of the Lact. casei CECT 4043 and L. lactis CECT 539 in
the GIT, permanently as a result of the colonization of the
intestinal mucus, or temporarily and dependent on the diet
consumed by the birds. Another possible reason to explain
the increase in LAB counts could be the growth of other
epiphytic LAB due to the probiotic cells supplemented in
the diet. Contrarily, chickens fed with avilamycin showed a
continuous decrease in LAB counts, which were at the end
of the experiment (42 days), signiﬁcantly lower than those of
the groups receiving the two probiotic preparations. These
results suggest that the feeding with avilamycin inhibits the
development of LAB. Also the highest counts of mesophilic
bacteria were found in chicks fed the two probiotic prepara-
tions. As mesophilic bacteria also include LAB, the increase
in mesophilic counts observed in the probiotic groups could
be due to the same reasons previously discussed for LAB
counts. Yu et al. [33] also reported that Arbor Acres broiler
fed a Lactobacillus reuteri Pg4 transformant in pens showed
higher total aerobic and Lactobacillus spp. counts in the
ileum and caecum than unsupplemented control birds. In
conclusion, the experimental system chosen in this ﬁrst trial
for the handling of animals, which reduces their contact with
faeces,couldmaskapotentialprotectiveeﬀectofprobioticor
antibiotic.Theseresultssuggestedtheneedofchoosingother
handling conditions.
Then, in experiment 2, the eﬀect of the probiotic prepa-
rations containing Lact. casei CECT 4043 and L. lactis CECT
539 cultures was evaluated in wood shaving ﬂoor, using theThe Scientiﬁc World Journal 7
similar conditions of temperature, cycle of light, and han-
dling as the farm conditions. With this approach, the trans-
mission of microorganisms between animals could be facil-
itated. The medium-growth Sasso X44 chickens previously
used in the ﬁrst trial were replaced by Ross 308 broilers in
the second trial. In order to obtain a more accurate analysis,
boththenumberofanimalspertreatmentandthenumberof
replicateswereincreased.Additionally,afeedbasedonbarley
and wheat was used to promote intestinal adverse conditions
that could be reversed or improved by using a probiotic
treatment. These cereals contain high amounts of nonstarch
polysaccharides (NSPs), which have “anti-nutritive eﬀects”
and increase the viscosity of the intestinal content [34]. The
use of barley can deteriorate the intestinal structure, causing
decrease of length and width of villi and their atrophy [35,
36]. Otherwise, Hofshagen and Kaldhusdal [37]o b s e r v e d
that the counts of Lactobacillusand Streptococcusstrains were
higherinchickens fedwithdiets basedoncornthanchickens
fed diets with barley. Moreover, Dalloul et al. [38]o b s e r v e d
an increase in resistance to coccidiosis in chickens fed with
a Lactobacillus-based probiotic diet. These results support
the hypothesis that these bacteria could control the necrotic
enteritis and it could be expected that the probiotic feed used
in this trial would protect against this infection.
In this second experiment the FCE values of broilers fed
with Lact. casei CECT 4043 preparation were lower (P<
0.10) than that of the broilers fed with the control diet at 16
and 31 days. With respect to avilamycin, the decrease of FCE
was statistically signiﬁcant (P<0.05) in both periods. This
positive eﬀect of Lactobacillus-supplemented diets on FCE
hasbeenpreviouslyreported.Thus,layinghens,thatreceived
L. acidophilus supplemented diets for a 48-week period [39],
had signiﬁcantly better FCE than control birds. In the same
way, the addition of either the single L. acidophilus or a
mixture of 12 Lactobacillus cultures signiﬁcantly improved
FCE in broilers [14].
The use of the wheat and barley diet did not increase
mortalityinanyofthetreatments.Thus,inthesecondexper-
iment,slighterandsubclinicnecroticenteritiscouldoccur,as
this type of enteritidis is asymptomatic [40]. Consequently,
it is probable that the nutritional stress induced in this trial
was not enough to see the growth-stimulating eﬀects of the
probiotic bacteria in animal exposed to stress reported by
other authors [41, 42].
In experiment 1, no signiﬁcant diﬀerences were found
between treatments in total coliform counts in the whole
intestinal tract (Figure 1). However, it has been reported that
bacterial distribution along the gastrointestinal tract is not
uniform [33]. The high acidity in the stomach as well as the
concentration of bile components in the proximal intestine
determines a strain selection [43] and reduces the bacteria
counts in the proximal segments of intestine, crop, and
ileum, in comparison with the caecum. But the homogeniza-
tion of the contents of the whole intestine could minimize
diﬀerences among the diﬀerent segments. In this manner,
Jin et al. [14] did not observe signiﬁcant diﬀerences in the
coliformpopulationinthesmallintestineofbroilersfeddiets
supplemented with Lactobacillus during the experimental
period, although the number of coliforms was signiﬁcantly
reduced in the caeca. For these reasons, and considering
that the caecum is a distal part where more favourable con-
ditions for bacterial development exist, in experiment 2,
this part was used to analyze the number of total coliform
counts. However, no signiﬁcant diﬀerences (P<0.05)
were found in total coliform counts between the treatments
(Figure 2).
Probiotics inhibit the adhesion of certain pathogenic
bacteria such as E. coli and Salmonella enterica to the epithe-
lial cells in vitro [44]. Competitive binding to receptors or
the stimulation of host factors such as the production of
mucin has been proposed as possible reasons to explain this
inhibition [45]. However, not always inhibitory eﬀects of
probiotic strains on the growth of coliforms are observed
in in vivo trials because host-dependent mechanisms are
important in reducing the coliform level [46]. Guerra et al.
[1], reported that viable coliform counts in pigs fed L.
lactis CECT 539 and Lact. casei CECT 4043 preparations
dropped on average for 1.8 and 1.4 log units, respectively
mean; while viable coliform counts did not change in the
controlgroup.However,inthecurrentexperiment,theabove
discussed coliform counts reduction was not observed. The
host-dependent theory suggested by Meimandipour et al.
[46] could be used to explain this fact.
On the other hand, when Lact. casei CECT 4043 prepa-
ration was tested as probiotic in pigs, the mean ﬁnal BWG
and FI values were higher than those observed in the control
group [1]. However, these researchers did not observe signif-
icant diﬀerences in FCE between the two groups receiving
probiotic preparations and the control group. In contrast,
the results of present study showed that, by day 31, the ﬁnal
BWG values in chickens receiving the diﬀerent diets were
not signiﬁcantly diﬀerent (Table 4), but the animals fed Lact.
casei CECT 4043 preparation improved their ﬁnal FCE in
comparison to chickens fed avilamycin.
However, it is worth highlighting that diﬀerences usually
found in BWG between chickens fed with antibiotics and
chickens fed with diets without growth promoters were
not present in this case (Tables 3 and 4). Patterson and
Burkholder [10] recommended that studies in which there is
no response to the growth promotant antibiotics should not
be considered negative for the probiotic treatment. Then, the
lack of diﬀerences between antibiotic and control groups in
both experiments (medium-growth Sasso X44 chickens and
Ross 308 broilers) suggests that the probiotic eﬀect of Lact.
casei CECT 4043 preparation observed in chickens has been
of minor magnitude because of the good condition of the
animals.
5. Conclusions
The ability of Lact. casei CECT 4043 to improve the FCE in
chickens, together with its capability to stimulate the growth
and to reduce coliform counts in the faeces of postweaning
piglets, indicates that the probiotic Lact. casei CECT 4043
preparation could be successfully used as a feed additive for
the animal feed industry. In addition the diﬀerent probiotic
eﬀect observed in pigs and broilers supports the hypothesis8 The Scientiﬁc World Journal
that probiotic mechanisms are host dependent. The results
obtained in this study reinforce previous reports on the pro-
biotic eﬀect of Lactobacillus sp. on chicken and pig growth.
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